25.95
-3.89%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Applied BioCode
Its shares trade on Taiwan Stock Exchange under the ticker 6598.TW. It has been listed since 9 February 2017. In the fiscal year to 31 December 2025, it reported revenue of TWD 475.2m and a net loss of TWD 201.2m. At that date it held total assets of TWD 1.01bn and shareholders' equity of TWD 643.2m.
Applied BioCode Corp. designs, develops, manufactures and commercializes multiplex testing products for in-vitro diagnostics market. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-09. The firm's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The firm sells in the United States, Europe and Asia markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 9 Feb 2017
- Website
- apbiocode.com ↗
Leadership
Pay as last reported
- Mr. Jia-Long LeeChairman of the Board, since 2016
- Mr. Zohn-Zen HoFounder, Chief Technology Officer, General Manager, Director, since 2008
- Mr. Liang-Kai HuangChief Financial Officer, Corporate Governance Officer
- Mr. Michael AyeVice President-Molecular Products
- Mr. Donald WongVice President-Productions
- Mr. Youning ChenDeputy General Manager-Taiwan Sub-Subsidiary
- Gerald KowalskiDeputy General Manager-Operation
- Jim LeighDeputy General Manager-Sales
- Mr. Zhaogu ChenManager of Accounting
- Mr. Benjamin JenDirector
- Lizzie LeeDirector
- Mr. Wen-Jing TsaiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Applied BioCode Corp has a strong and experienced team of scientists and researchers, enabling them to develop innovative products and solutions for the healthcare industry. The company has a diverse product portfolio, offering a range of diagnostic tests and systems to cater to various medical needs. Their advanced technology and automated systems provide accurate and efficient results, enhancing patient care.
Weaknesses
- One of the weaknesses of Applied BioCode Corp is its relatively limited market presence compared to some competitors. They may face challenges in establishing themselves as a recognized brand in the highly competitive healthcare industry. Additionally, the company's dependency on third-party suppliers for certain components or materials may pose a risk to their supply chain management.
Opportunities
- Applied BioCode Corp has opportunities to expand its market reach by targeting emerging markets and exploring collaborations with strategic partners worldwide. With the growing demand for personalized medicine and precision diagnostics, the company can further capitalize on its technology and expertise. They can also leverage advancements in digital health and data analytics to enhance their product offerings and improve patient outcomes.
Threats
- The healthcare industry is subject to rigorous regulations and standards, which can pose challenges for companies like Applied BioCode Corp. Compliance with these regulations and obtaining necessary approvals for their products can be time-consuming and costly. Additionally, the company faces competition from established players in the diagnostic industry, who may have greater resources and market presence.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.